Product
Glipizide
Name
Glucotrol XL
INN Name
Glipizide
FDA Approved
Yes
6 clinical trials
2 organizations
13 indications
2 documents
Indication
Diabetes MellitusIndication
Type 2Indication
Type 2 Diabetes MellitusIndication
Cardiovascular DiseasesIndication
Pancreatic CancerIndication
Pancreatic CarcinomaIndication
Pancreatic Ductal AdenocarcinomaIndication
Pancreatic Cancer MetastaticIndication
Diabetes Mellitus Type 2Indication
HyperglycemiaIndication
AtherosclerosisIndication
Type 2 DiabetesIndication
Insulin ResistanceClinical trial
Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in HumansStatus: Active (not recruiting), Estimated PCD: 2015-12-01
Clinical trial
Comparison of Type 2 Diabetes Pharmacotherapy Regimens Using Targeted LearningStatus: Recruiting, Estimated PCD: 2024-06-30
Clinical trial
Sulfonylurea Safety and Effectiveness (SUSS) for Patients With Hyperglycemia and Pancreatic Ductal Adenocarcinoma: A Pragmatic Clinical Trial and Accompanying Retrospective RevieStatus: Recruiting, Estimated PCD: 2025-12-05
Clinical trial
Effect of Farxiga on Renal Function and Size in Type 2 Diabetic Patients With HyperfiltrationStatus: Completed, Estimated PCD: 2023-07-11
Clinical trial
A Pilot Study of Outpatient Discharge Therapy With Saxagliptin + Metformin XR or Sulphonylurea for Recently Diagnosed Type 2 Diabetes Presenting With Severe HyperglycemiaStatus: Completed, Estimated PCD: 2015-07-25
Clinical trial
Ertugliflozin: Cardioprotective Effects on Epicardial FatStatus: Active (not recruiting), Estimated PCD: 2023-12-31
Document
DailyMed Label: Glucotrol XLOrganization
Physicians Total Care, Inc.Document
DailyMed Label: GlipizideOrganization
RedPharm Drug, Inc.